|
1
|
Hage WD, Aboulafia AJ and Aboulafia DM:
Incidence, location, and diagnostic evaluation of metastatic bone
disease. Orthop Clin North Am. 31:515–528. vii2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ricci AI, Wodajo FM and Malawer M:
Metastatic carcinoma of the long bones. Am Fam Physician.
76:1489–1494. 2007.PubMed/NCBI
|
|
3
|
Ekström K, Hjalgrim H, Brandt L, Baecklund
E, Klareskog L, Ekbom A and Askling J: Risk of malignant lymphomas
in patients with rheumatoid arthritis and in their first-degree
relatives. Arthritis Rheum. 48:963–970. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harris NL and Swerdlow SH:
Methotrexate-associated lymphoproliferative disorders. Jaffe ES,
Harris NL, Stein H and Vardiman JW: Pathology and genetics, tumours
of haematopoietic and lymphoid tissues, World Health Organization
classification of tumours Lyon: IARC Press; pp. pp270–271. 2001
|
|
5
|
Hoshida Y, Xu JX, Fujita S, Nakamichi I,
Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T and
Aozasa K: Lymphoproliferative disorders in rheumatoid arthritis:
Clinicopathological analysis of 76 cases in relation to
methotrexate medication. J Rheumatol. 34:322–331. 2007.PubMed/NCBI
|
|
6
|
Ministry of Health Labour Welfare
Rheumatoid arthritis and allergy information. 6:123–154. 2010.
|
|
7
|
Heldmann F and Braun J: Perioperative use
of methotrexate. Clin Exp Rheumatol. 28 5 Suppl 61:S110–S113.
2010.PubMed/NCBI
|
|
8
|
Miyazaki T, Fujimaki K, Shirasugi Y,
Yoshiba F, Ohsaka M, Miyazaki K, Yamazaki E, Sakai R, Tamaru J,
Kishi K, et al: Remission of lymphoma after withdrawal of
methotrexate in rheumatoid arthritis: Relationship with type of
latent Epstein-Barr virus infection. Am J Hematol. 82:1106–1109.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kameda T, Dobashi H, Miyatake N, Inoo M,
Onishi I, Kurata N, Mitsunaka H, Kawakami K, Fukumoto T, Susaki K,
et al: Association of higher methotrexate dose with
lymphoproliferative disease onset in rheumatoid arthritis patients.
Arthritis Care Res (Hoboken). 66:1302–1309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mariette X, Cazals-Hatem D, Warszawki J,
Liote F, Balandraud N and Sibilia J: Investigators of the Club
Rhumatismes et Inflammation; Lymphomas in rheumatoid arthritis
patients treated with methotrexate: A 3-year prospective study in
France. Blood. 99:3909–3915. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoshida Y and Aozasa K: Malignancies in
organ transplant recipients. Pathol Int. 54:649–658. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nalesnik MA, Jaffe R, Starzl TE, Demetris
AJ, Porter K, Burnham JA, Makowka L, Ho M and Locker J: The
pathology of posttransplant lymphoproliferative disorders occurring
in the setting of cyclosporine A-prednisone immunosuppression. Am J
Pathol. 133:173–192. 1988.PubMed/NCBI
|
|
13
|
Kamel OW, Van de Rijin M, Weiss LM, Del
Zoppo GJ, Hench PK, Robbins BA, Montgomery PG, Warnke RA and
Dorfman RF: Brief report: Reversible lymphomas associated with
Epstein-Barr virus occurring during methotrexate therapy for
rheumatoid arthritis and dermatomyositis. N Engl J Med.
328:1317–1321. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng WH, Cohen JI, Fischer S, Li L,
Sneller M, Goldbach-Mansky R, Raab-Traub N, Delecluse HJ and Kenney
SC: Reactivation of latent Epstein-Barr virus by methotrexate: A
potential contributor to methotrexate-associated lymphomas. J Natl
Cancer Inst. 96:1691–1702. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hans CP, Weisenburger OD, Greiner TC,
Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E,
Braziel RM, Jaffe ES, et al: Confirmation of the molecular
classification of diffuse large B-cell lymphoma by
immunohistochemistry using a tissue microarray. Blood. 103:275–282.
2004. View Article : Google Scholar : PubMed/NCBI
|
